What is Graves-Basedow Disease?

Reading time: 1 min

Graves-Basedow Disease (GBD) is the most common form of autoimmune hyperthyroidism, in which the thyroid is activated by antibodies that stimulate the thyroid hormone-producing cells. In addition to causing hyperthyroidism and diffuse enlargement of the thyroid gland, this disease typically affects the eyes and, in some cases, also the skin. 

Graves’ Disease explained in first person

Professionals and patients explain how you live with the disease
It is a rare but well-understood condition, and we can treat it.

GBD is caused by antibodies that bind to and activate the thyroid-stimulating hormone (TSH) receptor, anti-TSH receptor antibody (TRAb) or thyroid-stimulating immunoglobulin (TSI). This activation stimulates an enlargement (hypertrophy) and excess (hyperplasia) of thyroid cells by increasing the production of the hormones T3 and T4.

How many people are affected?

Graves' disease accounts for 60-80% of all causes of thyrotoxicosis (excess thyroid hormones in the blood), varying according to the population studied. It is more prevalent in women (10:1) and has a peak incidence between the ages of 40-60.  

Información general de Thyroid diseases

Consulta toda la información relacionada con Thyroid diseases

Read more

Substantiated information by:

Felicia Alexandra Hanzu
Mireia Mora Porta

Published: 11 June 2021
Updated: 11 June 2021

The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.


Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.